AzTrials
AzTrials

AddictionPPJNCT03903159

Piloting "Positive Peer Journaling" a Journaling Practice to Support Recovery From Addiction

A study testing Positive Peer Journaling (PPJ) in people with Addiction, run by University of Minnesota at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main objective of this study is development of the Positive Peer Journaling (PPJ) intervention and the feasibility, acceptability, and logistics of treatment delivery. A second objective is to observe whether PPJ is associated with improvement in hypothesized outcomes. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Addiction
What is being tested?
Positive Peer Journaling (PPJ)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteUnited States
Study dates
29 Jan 2019to 30 Sep 2019
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • minimum 18 years of age,
  • meet DSM-V criteria for past-year SUD as primary or secondary diagnosis,
  • English literacy sufficient to make short written lists needed to complete PPJ and homework assessments,
  • minimum 2 weeks sustained abstinence,
  • completed first 2 weeks of treatment at Wayside (approximately 2 weeks), a residential substance use disorder treatment program and the recruitment site,
  • priority will go to participants who are from or moving back to a rural area or small town defined as a population less than 10,500,
Show all 10Show fewer
  • agree to be audio recorded in group meetings and in individual meetings with research staff,
  • currently are clients in the Wayside residential program,
  • participants must be English speaking and literacy must be strong enough to write short lists and to understand the questions asked in the questionnaires.
  • Priority will go to women who will be residing at Wayside for the duration of the study activities (and not moving out after one week, for example).

Who cannot join

  • presence of a psychotic disorder, psychiatric condition (e.g., suicidal ideation), or cognitive impairment (e.g., severe dementia, traumatic brain injury) limiting ability to give consent and/or participate in the study;
  • severe psychiatric illness (current schizophrenia, major depression with suicidal ideation);
  • personality disorders that would interfere with satisfactory participation in or completion of the study protocol,
  • inability to give informed, voluntary consent to participate,
  • lack of sufficient English literacy to participate, defined as inability to make a list of 5 things they did yesterday and inability to understand questionnaire items,
  • any impairment, activity, or situation that in the judgement of the research staff would prevent satisfactory participation in or completion of the study protocol.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Wayside Women's Treatment Center

    Saint Louis Park, Minnesota, 55416

Other trials in United States

About this study

Official title: Addiction Recovery in a Rural Minnesota Community: Piloting "Positive Peer Journaling" Part II

The main objective of this study is development of the Positive Peer Journaling (PPJ) intervention and the feasibility, acceptability, and logistics of treatment delivery. A second objective is to observe whether PPJ is associated with improvement in hypothesized outcomes. The primary outcomes the investigators will examine are enhanced treatment retention and reduced recurrence of substance use. The investigators will also explore the association between the intervention and a set of hypothesized mediators of the effect of the intervention on outcomes, e.g., improvement in mood and satisfaction with recovery.

Conditions
Addiction
Being tested
Positive Peer Journaling (PPJ)
Medical subject headings
Behavior, Addictive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Positive Peer Journaling (PPJ)Behavioural

    PPJ is a journaling practice to support addiction recovery. PPJ encourages past 24 hour review and upcoming 24 hour planning to improve quality of life in recovery and reduce relapse. PPJ uses standard lined journals with column headings under which individuals make bullet-pointed lists. On the left hand page, past 24 hours is recalled, itemizing "good" and "bad" things that happened and things for which one is grateful. Wishes for others are also expressed on this page. On the right hand page, values-based activities for the upcoming 24 hours are planned via headings representing valued life domains such as "recovery," "work/school," "spirituality," "home and household," and "health."

Study groups in NCT03903159
Study groupRoleWhat they receive
Treatment GroupOtherPositive Peer Journaling (PPJ)
Receives: Behavioral: Positive Peer Journaling (PPJ)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Treatment Retention

    Percentage of participants who were retained in treatment at the host facility until the end of the study or who left the residential treatment facility on good terms during the course of the study.

    Measured: 8 weeks

  2. Substance Use

    Evidence that the individual used drugs or alcohol during the intervention period. This will be assessed via positive drug screen (urine test or breathalizer) or participant self-report of substance use. Reported as the number of participants who use illicit substances during the study.

    Measured: 8 weeks

  3. Percentage of Group Sessions Attended

    Percentage of group sessions will be calculated by taking the number of group sessions attended divided by total number of group sessions offered. Outcome is reported as the overall percentage of group attendance for all 15 participants combined.

    Measured: 8 weeks

  4. Number of PPJ Journal Entries Made

    Total count of the number of PPJ journal entries made over the course of the study

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Apr 2019
  2. Study start29 Jan 2019
  3. Primary completion30 Sep 2019
  4. Study completion30 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03903159
Sponsor's protocol ID
STUDY00004619
Acronym
PPJ
Status last verified
Aug 2021
First submitted
18 Jan 2019
Last updated
26 Aug 2021
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Positive Peer Journaling (PPJ) in people with Addiction, run by University of Minnesota at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 26 Aug 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Treatment Retention (time frame: 8 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
PPJ Clinical Trial NCT03903159 | AzTrials